PRMT3 and hepatocellular carcinoma: Recent studies have implicated the histone deacetylase LSD1 and the arginine methyltransferase PRMT3 as key drivers of oxaliplatin resistance in HCC [2, 15], highlighting the importance of epigenetic regulation in this context.